CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 43)
18 Sep 2023 Chinese catering industry is...
CROSBY Research – Xiabuxiabu (520 HK/BUY): A little pot goes a long way
18 Sep 2023 Chinese catering industry is...
CROSBY Research – Channel Micron (2115 HK/BUY): Slower China business but strong momentum in Malaysia and Europe
07 Sep 2023 Channel Micron’s 1H23 revenu...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 42)
04 Sep 2023 China saw net foreign capita...
CROSBY Research – Suntien Green Energy (956 HK/BUY): NG/Wind NP down by 48%/8% YoY
04 Sep 2023 1H23 revenue was down by 1.7...
CROSBY Research – NFI (1837 HK/BUY): New channel business continued its growth momentum with 8,135 POS
31 Aug 2023 NFI’s 1H23 revenue was up by...
CROSBY Research – IGG (799 HK/BUY): Multiple growth drivers from Doomsday, Viking Rise, and App business
30 Aug 2023 IGG announced 1H23 results w...
CROSBY Research – China Lesso (2128 HK/BUY): A resilient set of 1H23 results
29 Aug 2023 Despite the market uncertain...
CROSBY Research – Wasion Holdings (3393 HK/BUY): A solid set of 1H23 results, indicating a good FY23
28 Aug 2023 Wasion’s 1H23 turnover incre...
CROSBY Research – Sunny Optical (2382 HK/BUY): HLS/HCM shipment bottom out and sequential GPM improvement in 2H23
28 Aug 2023 Sunny reported 1H23 revenue...
CROSBY Research – Anta (2020 HK/BUY): Solid 1H23 results with expanding OPM
25 Aug 2023 Anta’s 1H23 revenue was up b...
CROSBY Research – Canvest (1381 HK/BUY): Higher revenue contribution from operation segment
25 Aug 2023 1H23 revenue down by 28% YoY...
CROSBY Research – Xtep (1368 HK/BUY): Solid 1H23 revenue growth, full year sales growth target 15-20% YoY
24 Aug 2023 Xtep’s 1H23 revenue was up b...
CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23
24 Aug 2023 In 1H23, Vincent Medical’s (...
CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings
22 Aug 2023 The company reported a 6.4%...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)
21 Aug 2023 Hong Kong’s population...
CROSBY Research – China Lilang (1234 HK): Single digit growth in 1H23
18 Aug 2023 The company reported a 6.7%...
CROSBY Research – 361 Degrees (1361 HK/BUY): Promising outlook
17 Aug 2023 1H23 revenue increased by 18...
CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum
16 Aug 2023 Pentamaster’s 2Q23 revenue i...
CROSBY Research – Greentech(1257 HK/BUY): Increasing EBITDA for its biomass segment
15 Aug 2023 CEG’s 1H23 revenue was down...